TreeFrog Therapeutics at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
TreeFrog Therapeutics takes part in 4 sessions at Cell 2026 in London. Its sessions focus on making cell therapies sustainable, both as a business and in reaching patients, and on how far AI is ready for safe use. A more technical thread covers predictive scaling to bridge process development and manufacturing.
| Organization | Cell 2026 Attendance |
|---|---|
TreeFrog Therapeutics Bordeaux, France | |
Develops cell therapies from pluripotent stem cells grown in its C-Stem 3D encapsulation platform, with a lead program in Parkinson's disease. | Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? Digital biomanufacturing and AI Panel Fri Nov 13 9:25am–9:50am Talk Fri Nov 13 11:40am–12:05pm Bridging Development and Manufacturing Through Predictive Scaling Manufacturing and CMCCell culture and upstream processing Talk Fri Nov 13 2:45pm–3:10pm Cell Therapy: From Therapeutic Potential To Sustainable Patient Access Cell and gene therapy |
Instantly find 20 buyers from TreeFrog Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction